The CEO of Physiomics plc is to step down next year.

Peter Sargent will leave the mathematical modelling, data science and biometrics company – which supports the development of new therapeutics and personalised medicine solutions – with effect from 29th May 2026.

The company has commenced its search to appoint a new CEO. Dr Jim Millen, currently non-executive chairman, will be available to resume the position of executive chairman from the date of Dr Sargent’s departure, for as long as required.

Dr Millen was formerly the CEO of the company from 2016 to 2024, during which time he grew the business from total income of under £300k to a peak of over £900k, as well as securing a major contract with long-term client Merck KGaA and kicking off the company’s personalised medicine initiative.